In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease
Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…
Read More
Samsung Biologics Accelerates Global Expansion with Strategic US Acquisition and PolyPeptide Deal
South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has embarked on a significant phase of global expansion, marked…
Read More
Biotech Sector Sees Major Leaps in Multiomics, Cell Research Accessibility, and Strategic Leadership
The global biotechnology landscape witnessed a week of pivotal advancements, marked by significant strides in multiomics research, enhanced accessibility to…
Read More
Navigating the New Frontier: American Biotech’s Strategic Imperatives Amidst Global Competition and Shifting Investment Tides
For several years, the landscape for American biotechnology firms has grown increasingly challenging, with success becoming a more elusive commodity.…
Read More
Arrowfly Emerges as the New Corporate Identity for WTWH Media, Signaling Strategic Expansion and Market Consolidation
Cleveland, Ohio – In a significant corporate development signaling a strategic evolution and a unified market approach, WTWH Media, the…
Read More
MSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic Diversification
The pharmaceutical landscape has been significantly reshaped with MSD (Merck & Co.) achieving a monumental victory: the US Food and…
Read More
WTWH Media Rebrands to Arrowfly, Signaling Strategic Evolution in B2B Information and Events Landscape
Cleveland-based WTWH Media, a prominent and diversified entity within the business-to-business (B2B) media and events sector, officially announced its corporate…
Read More
Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases
Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…
Read More
Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care
The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…
Read More
